Home/Filings/4/0001209191-16-121285
4//SEC Filing

EnteroMedics Inc 4

Accession 0001209191-16-121285

CIK 0001371217operating

Filed

May 17, 8:00 PM ET

Accepted

May 18, 4:36 PM ET

Size

6.5 KB

Accession

0001209191-16-121285

Insider Transaction Report

Form 4
Period: 2016-05-16
GLADNEY DAN W
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2015-05-16$0.72/sh+84,745$61,288134,745 total
Holdings
  • Stock Option (right to buy)

    Exercise: $3.75From: 2016-10-28Exp: 2025-10-28Common Stock (516,666 underlying)
    516,666
Footnotes (2)
  • [F1]On January 6, 2016, EnteroMedics Inc. effected a 1-for-15 reverse stock split of its issued and outstanding shares of common stock, par value $0.01 per share, resulting in a proportional decrease in the total shares of common stock beneficially owned by the reporting person. all previously reported exercise prices, option grants and similar instruments convertible into common stock were proportionally adjusted to reflect the reverse split.
  • [F2]Vests as to 25% one year from the date of the employment agreement on the date noted and thereafter in cumulative installments of 1/36th per month.

Issuer

EnteroMedics Inc

CIK 0001371217

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001371217

Filing Metadata

Form type
4
Filed
May 17, 8:00 PM ET
Accepted
May 18, 4:36 PM ET
Size
6.5 KB